GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report)’s share price dropped 5.1% on Wednesday . Wells Fargo & Company increased their target price on shares of GoodRx from $3.50 to $5.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. Weiss Ratings upgraded shares of GoodRx from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday. Citigroup increased their price target on GoodRx from $4.00 to $5.00 and gave the stock a “buy” rating in a research report on Tuesday. On average, equities research analysts expect that GoodRx Holdings, Inc. will post 0.17 earnings per share for the current year.